Allianz Asset Management GmbH Has $3.25 Million Holdings in Chemed Corporation $CHE

Allianz Asset Management GmbH cut its stake in Chemed Corporation (NYSE:CHE) by 53.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,263 shares of the company’s stock after selling 8,278 shares during the period. Allianz Asset Management GmbH’s holdings in Chemed were worth $3,252,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of CHE. Creekmur Asset Management LLC bought a new position in Chemed in the 2nd quarter worth approximately $28,000. First Horizon Corp acquired a new stake in shares of Chemed in the 3rd quarter valued at $31,000. Parkside Financial Bank & Trust raised its position in shares of Chemed by 86.3% during the second quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock worth $46,000 after acquiring an additional 44 shares during the last quarter. Geneos Wealth Management Inc. raised its position in shares of Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after acquiring an additional 76 shares during the last quarter. Finally, Pilgrim Partners Asia Pte Ltd acquired a new position in shares of Chemed during the third quarter valued at $45,000. 95.85% of the stock is owned by institutional investors.

Insider Activity

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $437.55, for a total transaction of $875,100.00. Following the sale, the chief executive officer directly owned 94,197 shares in the company, valued at $41,215,897.35. This trade represents a 2.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 3.29% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages recently commented on CHE. Royal Bank Of Canada lowered their price objective on Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a research report on Monday, November 10th. Jefferies Financial Group lowered shares of Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Finally, Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Three analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Chemed currently has an average rating of “Moderate Buy” and a consensus target price of $555.50.

Chemed Price Performance

NYSE:CHE opened at $461.97 on Thursday. The business’s 50-day simple moving average is $438.06 and its 200-day simple moving average is $441.70. Chemed Corporation has a fifty-two week low of $408.42 and a fifty-two week high of $623.60. The stock has a market capitalization of $6.54 billion, a PE ratio of 24.43, a price-to-earnings-growth ratio of 2.20 and a beta of 0.44.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.